Biotechnology company Regeneron buying 23andMe for $256 million
The purchase is happening two months after the genetic testing company filed for Chapter 11 bankruptcy protection. |!| Albany
The purchase is happening two months after the genetic testing company filed for Chapter 11 bankruptcy protection. |!| Albany